article thumbnail

The Evolution from Hearing Aids to Wellness Devices

HIT Consultant

Recently, the World Health Organization estimated more than 1.5 The health ramifications could be significant. Global sales of such wearable devices are expected to grow to $114 billion in 2028 from $36 billion in 2020, according to Fortune Business Insights. Better hearing leads to greater well-being.

Doctors 52
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

One Lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% Mild Lotion Recalled Due to an Impurity that May Pose Health Risks, 28 June 2024 Teva Canada Ltd. The deadline to submit feedback for this plan is 25 July 2024. is recalling one lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion in 60 mL bottles.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. The electronic certificate and the paper version are equally authentic.

article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

One Lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% Mild Lotion Recalled Due to an Impurity that May Pose Health Risks, 28 June 2024 Teva Canada Ltd. The deadline to submit feedback for this plan is 25 July 2024. is recalling one lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion in 60 mL bottles.

FDA 40